17 Apr 2018 | Lupus Foundation of America
Researchers at the Feinstein Institute for Medical Research on Long Island, New York have announced they are leading a nationwide clinical trial that will test the efficacy of a synthetic cannabinoid derivative, without mood-altering properties, for the treatment of joint inflammation in lupus.
12 Apr 2018 | Medscape
The problem stems partly from the fact that the federal government's restrictive marijuana research policies have not been overhauled in more than 40 years, researchers say.
9 Apr 2018 | Fox Business
According to two newly published studies in JAMA Internal Medicine, medical and recreational pot may offer a benefit to the American public: a reduction in opioid use.
9 Apr 2018 | Business Insider
Federal policies restricting marijuana research have made it difficult to study marijuana and produce cannabis-based drugs - but that isn't stopping pharmaceutical companies from doing it.
26 Mar 2018 | Philly.com
The medical cannabis program in Pennsylvania is about to enter unprecedented territory as it embarks on the nation’s first state-sanctioned research program.
23 Mar 2018 | Leafly
Trying to keep track of all the advances in medical cannabis research? Here are some brief summaries of some of the biggest headlines over the last few months
17 Mar 2018 | mg Cannabis Retailer
The European Journal of Internal Medicine (EJIM) has published a special issue for March titled "Cannabis in Medicine."
16 Mar 2018 | Huntington's Disease News
MMJ BioScience has been licensed in Canada to produce cannabis-derived medicines for testing in FDA-approved studies for Huntington’s disease.
13 Mar 2018 | Neurology Advisor
Cannabinoids are effective as an adjunctive treatment for reducing seizure frequency in pediatric-onset treatment-resistant epilepsy.
8 Mar 2018 | European Pharmaceutical Review
Naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures,